Creative Financial Designs Inc. ADV Reduces Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Creative Financial Designs Inc. ADV lowered its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 51.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,258 shares of the company’s stock after selling 1,331 shares during the period. Creative Financial Designs Inc. ADV’s holdings in GE HealthCare Technologies were worth $98,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in GEHC. Cathy Pareto & Associates Inc. purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $670,000. Principal Financial Group Inc. raised its position in shares of GE HealthCare Technologies by 1.9% in the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after buying an additional 19,010 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of GE HealthCare Technologies in the third quarter worth $1,396,000. Everence Capital Management Inc. raised its position in shares of GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock worth $1,475,000 after buying an additional 10,220 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its position in shares of GE HealthCare Technologies by 9.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company’s stock worth $13,702,000 after buying an additional 12,908 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.7 %

Shares of NASDAQ:GEHC opened at $81.81 on Friday. The stock’s 50-day moving average price is $87.08 and its 200-day moving average price is $86.05. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The stock has a market capitalization of $37.41 billion, a P/E ratio of 18.89, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on GEHC shares. Citigroup increased their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their target price for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.